Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

被引:0
|
作者
Salvatore Crisafulli
Nicoletta Luxi
Raffaele Coppini
Annalisa Capuano
Cristina Scavone
Alessia Zinzi
Simona Vecchi
Graziano Onder
Janet Sultana
Gianluca Trifirò
机构
[1] University of Messina,Department of Biomedical and Dental Sciences and Morphofunctional Imaging
[2] University of Verona,Department of Diagnostics and Public Health
[3] University of Florence,Section of Pharmacology, Department of Neurology, Psychology, Drug Sciences and Child Health
[4] University of Campania “L. Vanvitelli”,Department of Experimental Medicine
[5] Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology,College of Medicine and Health
[6] Department of Epidemiology,undefined
[7] Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging,undefined
[8] Pharmacy Department,undefined
[9] Mater Dei Hospital,undefined
[10] University of Exeter,undefined
来源
关键词
Deprescribing; Ant-hypertensive drugs; Multimorbidity; Polypharmacy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Decoding the efficacy and safety profiles of anti-hypertensive agents by targeting RAAS: A systematic review and meta-analysis of clinical trials
    Rampengan, Starry Homenta
    Rampengan, Derren David Christian Homenta
    Ramadhan, Roy Novri
    Willyanto, Sebastian Emmanuel
    Jowono, Josh Nathaniel
    Tjandra, Kevin Christian
    Nugraha, Laksmana Adi Krista
    Arini, Merita
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2025, 22 (03):
  • [22] ENHANCEMENT OF ANTI-HYPERTENSIVE EFFECT OF METHYLDOPA AND OTHER ANTI-HYPERTENSIVE DRUGS BY CARBIDOPA IN SPONTANEOUSLY HYPERTENSIVE RATS
    SCRIABINE, A
    LUDDEN, CT
    STONE, CA
    WURTMAN, RJ
    WATKINS, CJ
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 51 : S407 - S410
  • [23] Public reporting of black participation in anti-hypertensive drug clinical trials
    Green, Michael D.
    Dalmage, Mahalia R.
    Lusk, Jay B.
    Kadhim, Emilie F.
    Skalla, Lesley A.
    O'Brien, Emily C.
    AMERICAN HEART JOURNAL, 2023, 258 : 129 - 139
  • [24] The economic return of performing pediatric anti-hypertensive drug clinical trials
    Baker-Smith, Carissa M.
    Benjamin, Daniel K., Jr.
    Murphy, Dianne
    Eisenstein, Eric L.
    Li, Jennifer S.
    CIRCULATION, 2007, 116 (16) : 822 - 822
  • [25] MEASUREMENT OF ADHERENCE TO ANTI-HYPERTENSIVE DRUGS IN ASIA
    Ma, Q.
    Kao, C.
    Miles, G.
    Chen, G.
    VALUE IN HEALTH, 2016, 19 (07) : A868 - A868
  • [26] ANTI-HYPERTENSIVE DRUGS AND BLOOD-LIPIDS
    ABADIE, E
    GAZETTE MEDICALE DE FRANCE, 1983, 90 (25): : 2415 - 2416
  • [27] COMPARISON OF LABETALOL WITH OTHER ANTI-HYPERTENSIVE DRUGS
    PRICHARD, BNC
    RICHARDS, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 : S41 - S47
  • [28] Chronotherapy with anti-hypertensive drugs and glaucoma Reply
    Hermida, Ramon C.
    MEDICINA CLINICA, 2016, 146 (01): : 46 - 47
  • [29] Effects of anti-hypertensive drugs on vessel rarefaction
    Battegay, Edouard J.
    de Miguel, Lourdes Sanchez
    Petrimpol, Marco
    Humar, Rok
    CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (02) : 151 - 157
  • [30] Statins As Anti-Hypertensive Therapy: A Systematic Review and Meta-Analysis
    Khan, Zahid
    Gul, Amresh
    Mlawa, Gideon
    Bhattacharjee, Priyadarshini
    Muhammad, Syed Aun
    Carpio, Jonard
    Yera, Hassan
    Wahinya, Maureen
    Kazeza, Axel P.
    Amin, Mehul S.
    Gupta, Animesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)